微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -0.94% | -100% | -1242.86% | 108/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -0.07% | -113.21% | 98.95% | 97/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -6.65% | -1107.58% | -396.27% | 115/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -1.34% | -339.29% | -185.11% | 112/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -0.47% | -634.09% | -188.68% | 106/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.53% | 0% | -19.7% | 89/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 0.66% | 1251.83% | 17.86% | 95/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 0.56% | 14.29% | 536.36% | 102/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.09% | -56% | -83.4% | 101/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.53% | 112% | 1024.96% | 88/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -0.06% | 45.89% | -111.69% | 107/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 0.49% | 133.79% | 145% | 108/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.2% | 112.35% | -20% | 111/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.25% | -24.24% | 336.07% | 104/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | -0.11% | -118.58% | 92.7% | 113/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | -1.45% | -158.47% | 10.49% | 113/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | -1.62% | -170.43% | -590.91% | 118/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 0.33% | -80.92% | -42.11% | 101/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 0.57% | -91.08% | -77.02% | 120/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 2.48% | -45.73% | 7.83% | 101/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 2.3% | -30.72% | 32.95% | 105/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.73% | 5.49% | -72.93% | 82/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 6.39% | 214.78% | 39.82% | 103/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 4.57% | 86.53% | 37.65% | 71/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 3.32% | 62.75% | 102.44% | 84/141 | 15.17% | 杭州博拓生物科技 | 108.13% | 行业排名> |
| 2020-03-31 | 1.64% | 27.13% | -19.21% | 48/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 2.03% | -18.8% | -17.14% | 104/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 2.45% | -45.07% | 20.1% | 58/141 | 10.54% | 祥生医疗科技 | 28.56% | 行业排名> |
| 2019-06-30 | 2.04% | -48.09% | 58.14% | 61/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 1.29% | -46.25% | -48.4% | 39/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 2.5% | -71.3% | -43.95% | 94/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 4.46% | -43.47% | 13.49% | 44/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 3.93% | -22.64% | 63.75% | 37/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 2.4% | -19.19% | -72.45% | 25/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 8.71% | 34% | 10.39% | 71/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 7.89% | -3.78% | 55.31% | 27/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 5.08% | -9.12% | 71.04% | 33/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.97% | 0% | -54.31% | 17/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 6.5% | -32.57% | -20.73% | 66/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 8.2% | -0.24% | 46.69% | 17/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 5.59% | 13.39% | 88.22% | 24/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 2.97% | 18.33% | -69.19% | 13/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |